Skip to content
  • Sunday, 26 July 2026
  • 2:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Parabilis Medicines Aims for $475 Million Nasdaq IPO to Advance Lead Cancer Asset Zolucatetide
Pharmaceutical R&D

Parabilis Medicines Aims for $475 Million Nasdaq IPO to Advance Lead Cancer Asset Zolucatetide

Teuku Ryan Jun 6, 2026 0

Parabilis Medicines, a promising biotechnology firm, is strategically positioning itself for a significant public market debut, announcing its intention to…

Read More
Molecular & Cell Biology

Cellular Division’s Double-Edged Sword: How Different Failures Lead to Profoundly Different Cell Fates

Angie Faith Jun 2, 2026 0

The intricate symphony of cellular division, a fundamental process underpinning life itself, is a marvel of biological engineering. Every second,…

Read More
Molecular & Cell Biology

The Subtle Art of Cellular Division: How Different Failures Lead to Drastically Different Outcomes

Angie Faith May 25, 2026 0

Every second, in a microscopic ballet of biological precision, countless cells within the human body undergo division, a fundamental process…

Read More
Pharmaceutical R&D

Biopharma Leaders Urge Dr. Richard Pazdur to Lead FDA Amidst Crisis of Confidence

Teuku Ryan May 15, 2026 0

The leadership void at the U.S. Food and Drug Administration (FDA) has prompted a significant groundswell of support from the…

Read More
Advanced Materials Science

New Research Deciphers the Efficiency Paradox of Lead-Halide Perovskites in Next-Generation Solar Cells

Nila Kartika Wati May 2, 2026 0

The global transition toward renewable energy has long been anchored by silicon-based photovoltaic technology, a medium that demands extreme structural…

Read More
Advanced Materials Science

Structural Defects as Charge Highways Scientists Resolve the Mystery of Lead Halide Perovskite Efficiency

Nila Kartika Wati Apr 25, 2026 0

The global energy landscape is currently undergoing a radical transformation as researchers seek more efficient, cost-effective alternatives to traditional silicon-based…

Read More
Pharmaceutical R&D

Enanta Pharmaceuticals Poised to Lead Emerging RSV Therapeutics Market as Zelicapavir Advances to Phase III

Teuku Ryan Apr 24, 2026 0

Enanta Pharmaceuticals is strategically positioned to capture a significant share of the largely undeveloped market for respiratory syncytial virus (RSV)…

Read More
Advanced Materials Science

University of Manchester Scientists Lead Discovery of New Subatomic Particle at CERN’s Large Hadron Collider

Nila Kartika Wati Apr 15, 2026 0

In a landmark achievement for the field of particle physics, researchers from The University of Manchester have spearheaded the identification…

Read More

Posts pagination

1 2
TWiV 1287: Ancient Herpesviruses and Modern DementiaDrexel University Researchers Engineer High-Conductivity MXene Nanoscrolls Marking a Significant Leap in One-Dimensional NanotechnologyDeciphering the Distinct Roles of BET Proteins: A New Paradigm for Targeted Cancer Therapy Emerges from Max Planck ResearchNovo Nordisk’s new weight loss treatment inferior to Lilly’s tirzepatide
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ